INSIGHTS ON PHARMACEUTICAL LOGISTICS

• The Future Of RNA Manufacturing Starts With Raw Material Innovation

  Amid the mRNA and oligonucleotide therapeutic boom, sponsors and manufacturers are exploring how to make critical raw materials—capping agents, lipid nanoparticles, and RNA polymerase—more effective.

• A Temperature-Stable Replacement For Animal Trypsin In Cell Dissociation Applications

  Improve cell dissociation with a gentle, recombinant enzyme. This temperature-stable protease shows dissociation kinetics similar to porcine trypsin but with lower cell toxicity and greater overall purity.

• Top Safety Considerations In Biopharmaceutical Manufacturing

  Understanding top safety concerns, from combustible material handling and chemical exposure to HPAPIs, is the first step toward preventing accidents in biopharmaceutical manufacturing environments.

• Supply Resiliency For Bioprocessing Amid Global Volatility

  Build bioprocessing resiliency with strategic supply chain management. Learn to meet quality, compliance, and time-to-market demands amid global volatility with effective sourcing.

• Optimized Processes: A Guide To Lyophilization Cycle Development

  6/25/2024

  Review the essential phases of the lyophilization cycle — freezing, primary drying, and secondary drying — and critical success factors to achieve optimal product quality and stability.

• The Crucial Role Of Cleaning In Effective VPHP Decontamination For Isolators

  12/27/2024

  Effective isolator cleaning is crucial for vapor phase hydrogen peroxide (VPHP) decontamination. Proper tools, techniques, and training ensure sterility, and regulatory compliance.

• 5 Signs You've Outgrown Your Quality Management System (QMS)

  12/27/2024

  An outdated QMS limits growth. Explore how upgrading to an advanced, configurable system like MasterControl can ensure scalability, automation and innovation. 

• Strengthen Pharmaceutical Supply Chains With A U.S.-Based CDMO

  6/5/2025

  While certain ingredients require sourcing abroad, partnering with a U.S.-based company that owns its manufacturing assets allows for direct oversight of product quality and supply reliability.

• Biopharma Supply, Reimagined: Blarney, A Climate-Neutral Facility For Best-In-Class Filters

  11/11/2025

  Explore how a new, climate-neutral manufacturing facility strengthens biopharma supply chains. Understand the benefits of its advanced filtration technologies and commitment to environmental sustainability.